Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Another look at the pentoxifylline efficacy data for intermittent claudication.

D Gillings1, G Koch, T Reich

  • 1University of North Carolina, Chapel Hill.

Journal of Clinical Pharmacology
|August 1, 1987
PubMed
Summary

Pentoxifylline significantly improves walking distance for patients with intermittent claudication due to arterial disease. This analysis confirms its efficacy, introducing a new measure: minimum distance walked.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using a community clinical trials network for treatment, prevention, and control research: assuring access to state-of-the-art cancer care.

Cancer investigation·1995
Same author

Effect of a National Cancer Institute Clinical Alert on breast cancer practice patterns.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1994
Same author

Cancer prevention and control within the National Cancer Institute's clinical trials network: lessons from the Community Clinical Oncology Program.

Journal of the National Cancer Institute·1993
Same author

The relationship between plasma beta-endorphin, opioid receptor activity, and silent myocardial ischemia.

The Clinical journal of pain·1992
Same author

Tat contains a sequence related to snake neurotoxins.

AIDS (London, England)·1992
Same author

Interrelationships between left ventricular volume and output during exercise in healthy subjects.

Journal of applied physiology (Bethesda, Md. : 1985)·1992

Area of Science:

  • Vascular Medicine
  • Clinical Pharmacology

Background:

  • Intermittent claudication is a common symptom of peripheral artery disease.
  • Current treatments have limitations in efficacy and side effect profiles.

Purpose of the Study:

  • To reanalyze data from a trial on pentoxifylline for intermittent claudication.
  • To introduce and validate a new clinical efficacy measure: minimum distance walked.
  • To confirm the efficacy of pentoxifylline using intention-to-treat analysis.

Main Methods:

  • Seven-center, double-blind, parallel-group, randomized trial.
  • Intention-to-treat (ITT) population analysis.
  • Development and application of the minimum distance walked (MDW) metric.

Main Results:

Related Experiment Videos

  • Pentoxifylline demonstrated statistically significant superiority over placebo.
  • ITT analysis confirmed the efficacy of pentoxifylline.
  • The MDW measure corroborated the positive treatment effect.

Conclusions:

  • Pentoxifylline is an effective treatment for intermittent claudication.
  • The minimum distance walked is a valid and sensitive measure of clinical efficacy.
  • Intention-to-treat analysis reinforces the reliability of these findings.